164 related articles for article (PubMed ID: 15593119)
1. Activation-induced cytidine deaminase fails to induce a mutator phenotype in the human pre-B cell line Nalm-6.
Rückerl F; Bachl J
Eur J Immunol; 2005 Jan; 35(1):290-8. PubMed ID: 15593119
[TBL] [Abstract][Full Text] [Related]
2. Dual reporter system to dissect cis- and trans-effects influencing the mutation rate in a hypermutating cell line.
Ruckerl F; Mailhammer R; Bachl J
Mol Immunol; 2004 Nov; 41(12):1135-43. PubMed ID: 15482849
[TBL] [Abstract][Full Text] [Related]
3. Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines.
Rückerl F; Busse B; Bachl J
Mol Immunol; 2006 Apr; 43(10):1645-52. PubMed ID: 16310251
[TBL] [Abstract][Full Text] [Related]
4. The cytidine deaminase AID exhibits similar functional properties in yeast and mammals.
Rogozin IB; Pavlov YI
Mol Immunol; 2006 Mar; 43(9):1481-4. PubMed ID: 16219354
[TBL] [Abstract][Full Text] [Related]
5. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype.
Smit LA; Bende RJ; Aten J; Guikema JE; Aarts WM; van Noesel CJ
Cancer Res; 2003 Jul; 63(14):3894-8. PubMed ID: 12873980
[TBL] [Abstract][Full Text] [Related]
6. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells.
Pasqualucci L; Kitaura Y; Gu H; Dalla-Favera R
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):395-400. PubMed ID: 16387847
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma.
Greiner A; Tobollik S; Buettner M; Jungnickel B; Herrmann K; Kremmer E; Niedobitek G
J Pathol; 2005 Apr; 205(5):541-7. PubMed ID: 15732141
[TBL] [Abstract][Full Text] [Related]
8. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts.
Yoshikawa K; Okazaki IM; Eto T; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
Science; 2002 Jun; 296(5575):2033-6. PubMed ID: 12065838
[TBL] [Abstract][Full Text] [Related]
9. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
[TBL] [Abstract][Full Text] [Related]
10. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion.
Arakawa H; Hauschild J; Buerstedde JM
Science; 2002 Feb; 295(5558):1301-6. PubMed ID: 11847344
[TBL] [Abstract][Full Text] [Related]
11. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas.
Martin A; Bardwell PD; Woo CJ; Fan M; Shulman MJ; Scharff MD
Nature; 2002 Feb; 415(6873):802-6. PubMed ID: 11823785
[TBL] [Abstract][Full Text] [Related]
12. Target sequence accessibility limits activation-induced cytidine deaminase activity in primary mediastinal B-cell lymphoma.
Popov SW; Moldenhauer G; Wotschke B; Brüderlein S; Barth TF; Dorsch K; Ritz O; Möller P; Leithäuser F
Cancer Res; 2007 Jul; 67(14):6555-64. PubMed ID: 17638864
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of activation-induced cytidine deaminase in B cells.
Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutations and activation-induced cytidine deaminase (AID) expression in established rheumatoid factor-producing lymphoblastoid cell line.
Gil Y; Levy-Nabot S; Steinitz M; Laskov R
Mol Immunol; 2007 Jan; 44(4):494-505. PubMed ID: 16574227
[TBL] [Abstract][Full Text] [Related]
15. Role of AID in tumorigenesis.
Okazaki IM; Kotani A; Honjo T
Adv Immunol; 2007; 94():245-73. PubMed ID: 17560277
[TBL] [Abstract][Full Text] [Related]
16. Activation-induced deaminase: light and dark sides.
de Yébenes VG; Ramiro AR
Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038
[TBL] [Abstract][Full Text] [Related]
17. Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations.
Epeldegui M; Hung YP; McQuay A; Ambinder RF; Martínez-Maza O
Mol Immunol; 2007 Feb; 44(5):934-42. PubMed ID: 16730063
[TBL] [Abstract][Full Text] [Related]
18. Activation-induced cytidine deaminase splice variants are defective because of the lack of structural support for the catalytic site.
van Maldegem F; Jibodh RA; van Dijk R; Bende RJ; van Noesel CJ
J Immunol; 2010 Mar; 184(5):2487-91. PubMed ID: 20118283
[TBL] [Abstract][Full Text] [Related]
19. Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase.
Willenbrock K; Jungnickel B; Hansmann ML; Küppers R
Eur J Immunol; 2005 Oct; 35(10):3002-7. PubMed ID: 16180254
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific sensitivity to AID expression in transgenic mouse models.
Rucci F; Cattaneo L; Marrella V; Sacco MG; Sobacchi C; Lucchini F; Nicola S; Della Bella S; Villa ML; Imberti L; Gentili F; Montagna C; Tiveron C; Tatangelo L; Facchetti F; Vezzoni P; Villa A
Gene; 2006 Aug; 377():150-8. PubMed ID: 16787714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
